Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03392649 · ClinicalTrials.gov registry record · NA
Tragus Stimulation to Prevent Atrial Fibrillation After Cardiac Surgery
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
NCT03392649 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 81 participants.
The verdict
NCT03392649, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
Study Summary
Patients undergoing cardiac surgery, specifically a coronary artery bypass graft and/or heart valve replacement surgery, are at a higher risk for post-procedure atrial fibrillation (AF). AF is a condition in which the upper chambers of the heart do not contract normally and results in an irregular heartbeat. Recent studies have shown that tragus stimulation decreases the likelihood of AF in animals and humans. It has also been shown to reduce inflammation which may be related to post-procedure AF. Tragus stimulation involves stimulating a part of the outer ear, called the tragus, by sending a microcurrent through a small alligator clip. It is believed that tragus stimulation can affect the nervous system, which may reduce heart rate and lead to prevention of AF. The purpose of this study is to determine whether tragus stimulation in subjects undergoing cardiac surgery will lead to shorter occurrences, or even prevention, of AF.
Interventions
- DEVICE Parasym
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2018-03-09 |
| Est. Completion | 2021-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03392649
The ClinicalTrials.gov registry entry for NCT03392649 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Parasym is the first listed.
NCT03392649 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03392649 about?
NCT03392649 is a clinical study titled "Tragus Stimulation to Prevent Atrial Fibrillation After Cardiac Surgery". Patients undergoing cardiac surgery, specifically a coronary artery bypass graft and/or heart valve replacement surgery, are at a higher risk for post-procedure atrial fibrillation (AF). AF is a condition in which the upper chambers of the heart do not contract normally and results in an irregular h...
What is the current status of trial NCT03392649?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2018-03-09. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT03392649?
The interventions under investigation include: Parasym (DEVICE).
Who is sponsoring clinical trial NCT03392649?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.